← Back to patent-cliff list
CAS 122853-01-4
2,2,2-trifluoro-N-(2-(1-methyl-1H-indol-2-yl)ethyl)acetamide
Codes: ALOS-008
Application context (from source-drug indications)
Irritable bowel syndromeAlosetron Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Alosetron Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(1-methyl-1H-indol-2-yl)ethan-1-amine→2,2,2-trifluoro-N-(2-(1-methyl-1H-indol-2-yl)ethyl)acetamide→5-(chloromethyl)-N,N,4-trimethyl-1H-imidazole-1-sulfonamide→N-((1-(N,N-dimethylsulfamoyl)-5-methyl-1H-imidazol-4-yl)methyl)-2,2,2-trifluoro-N-(2-(1-methyl-1H-indol-2-yl)ethyl)acetamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.